Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial reactive oxygen species (mROS), primarily the superoxide anion, are chemically reactive molecules generated as byproducts of the mitochondrial electron transport chain during oxidative phosphorylation [1]. Under physiological conditions, mROS function as critical signaling molecules that regulate cellular processes such as autophagy, cell differentiation, and metabolic adaptation [2]. However, an imbalance between mROS production and the capacity of endogenous antioxidant systems leads to oxidative stress, which causes cumulative damage to mitochondrial DNA, lipids, and proteins [3]. This dysfunction is strongly implicated in the progression of neurodegenerative diseases, heart failure, and metabolic syndromes [4]. Pharmacological targeting of mROS often utilizes mitochondria-targeted antioxidants, which are engineered with lipophilic cations to penetrate the mitochondrial membrane and neutralize radicals at their source [5]. These interventions aim to mitigate oxidative damage without completely abolishing the essential signaling roles of mROS, representing a delicate therapeutic balance [6].
Mitochondria-targeted antioxidants typically utilize a lipophilic cation (like triphenylphosphonium) to accumulate within the mitochondrial matrix, where they directly scavenge superoxide and other reactive species or prevent their formation by stabilizing the electron transport chain.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial reactive oxygen species (mROS) (mROS).